Topics
Glioblastoma | Treatment | Off-label Medications | Glucocorticoids
Home > Publications > Topics > Glioblastoma > Treatment > Off-label Medications > Glucocorticoids
Segura Arderiu MM, Momin SMB, Pohl U, Chan H.
Dexamethasone-associated regression of
glioblastoma.
Surg
Neurol Int. 2025 Jun 13;16:245. doi:
10.25259/SNI_818_2024. PMID:
40656499. Case report. ˍ
Kurdi M, Kabli A, Alkhotani A, Alkhotani A, Bokhari R, Jastaniah
Z, Amjad R, Althoukhi H, Alsinani T, Alamoudi H, Baeesa S.
Impact
of corticosteroid administration on glioblastoma progression
before and after adjuvant treatments: recent updates on
contradictory findings and mechanistic interactions.
Front
Oncol. 2026 Mar 2;16:1774736. doi:
10.3389/fonc.2026.1774736. PMID:
41847699. ˍ
Liang B, Weil M.
Corticosteroids in
Glioblastoma Management: A Reconsideration of a 65-Year Practice.
J
Clin Oncol. 2026 Jul 22:JCO2600191. doi:
10.1200/JCO-26-00191. PMID:
42485601. ˍ